Search

Displaying results 4771 - 4780 of 7479 in total
  1. Drug

    Phellodendron amurense bark

    go.drugbank.com/drugs/DB14370
    Investigational

    It is not an approved drug.

  2. Drug

    SynKIR-110

    go.drugbank.com/drugs/DB17365
    Investigational

    SynKIR-110 are autologous T cells genetically engineered to express an anti-mesothelin killer immunoglobulin-like receptor-chimeric antigen receptor (KIR-CAR).

  3. Drug

    PRX-ASL

    go.drugbank.com/drugs/DB17679
    Experimental

    PRX-ASL is an intracellular enzyme replacement therapy designed to replace the missing or defective enzyme in patients with argininosuccinate lyase deficiency.

  4. Drug

    Lepunafusp alfa

    go.drugbank.com/drugs/DB19011
    Investigational

    Lepunafusp alfa is under investigation in clinical trial NCT04453085 (An Extension Study of JR-171-101 Study in Patients With MPS I).

  5. Drug

    Amber

    go.drugbank.com/drugs/DB14326
    Investigational

    It is not an approved drug.

  6. Drug

    Mangostin

    go.drugbank.com/drugs/DB14371
    Investigational

    It is not an approved drug.

  7. Drug

    Pumice

    go.drugbank.com/drugs/DB14374
    Investigational

    It is not an approved drug.

  8. Drug

    Peracetic acid

    go.drugbank.com/drugs/DB14556
    Investigational

    It has an acrid odor and is used as a disinfectant.

    Products: Peraflu D, Pu Us Pure
  9. Drug

    DCVax-L

    go.drugbank.com/drugs/DB17580
    Investigational

    DCVax-L is a personalized immunotherapy comprising an autologous vaccine with dendritic cells loaded _in vitro_ with autologous tumour lysate.

  10. Drug

    WVE-003

    go.drugbank.com/drugs/DB17870
    Investigational

    WVE-003 is an allele-selective antisense oligonucleotide that works to selectively reduce the toxic mutant huntingtin (mHTT) protein.[L46787]